AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome
- PMID: 32052923
- DOI: 10.1111/resp.13784
AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome
Abstract
Background and objective: Average volume-assured pressure support-automated expiratory positive airway pressure (AVAPS-AE) combines an automated positive expiratory pressure to maintain upper airway patency to an automated pressure support with a targeted tidal volume. The aim of this study was to compare the effects of 2-month AVAPS-AE ventilation versus pressure support (ST) ventilation on objective sleep quality in stable patients with OHS. Secondary outcomes included arterial blood gases, health-related quality of life, daytime sleepiness, subjective sleep quality and compliance to NIV.
Methods: This is a prospective multicentric randomized controlled trial. Consecutive OHS patients included had daytime Pa CO2 > 6 kPa, BMI ≥ 30 kg/m2 , clinical stability for more than 2 weeks and were naive from home NIV. PSG were analysed centrally by two independent experts. Primary endpoint was sleep quality improvement at 2 months.
Results: Among 69 trial patients, 60 patients had successful NIV setup. Baseline and follow-up PSG were available for 26 patients randomized in the ST group and 30 in the AVAPS-AE group. At baseline, Pa CO2 was 6.94 ± 0.71 kPa in the ST group and 6.61 ± 0.71 in the AVAPS-AE group (P = 0.032). No significant between-group difference was observed for objective sleep quality indices. Improvement in Pa CO2 was similar between groups with a mean reduction of -0.87 kPa (95% CI: -1.12 to -0.46) in the ST group versus -0.87 kPa (95% CI: -1.14 to -0.50) in the AVAPS-AE group (P = 0.984). Mean NIV use was 6.2 h per night in both groups (P = 0.93). NIV setup duration was shorter in the AVAPS-AE group (P = 0.012).
Conclusion: AVAPS-AE and ST ventilation for 2 months had similar impact on sleep quality and gas exchange.
Keywords: chronic respiratory failure; non-invasive ventilation; obesity hypoventilation syndrome; polysomnography; sleep apnoea.
© 2020 Asian Pacific Society of Respirology.
Comment in
-
Automated ventilator technology: Some answers and more questions.Respirology. 2020 Oct;25(10):1025-1026. doi: 10.1111/resp.13802. Epub 2020 Mar 11. Respirology. 2020. PMID: 32162396 No abstract available.
References
REFERENCES
-
- Janssens J-P, Derivaz S, Breitenstein E, de Muralt B, Fitting JW, Chevrolet JC, Rochat T. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 2003; 123: 67-79.
-
- Murphy PB, Davidson C, Hind MD, Simonds A, Williams AJ, Hopkinson NS, Moxham J, Polkey M, Hart N. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax 2012; 67: 727-34.
-
- Borel J-C, Tamisier R, Gonzalez-Bermejo J, Baguet JP, Monneret D, Arnol N, Roux-Lombard P, Wuyam B, Levy P, Pépin JL. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest 2012; 141: 692-702.
-
- Pérez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vázquez Caruncho M, Caballero Muinelos O, Alvarez Carro C. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005; 128: 587-94.
-
- Chouri-Pontarollo N, Borel J-C, Tamisier R, Wuyam B, Levy P, Pepin J-L. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest 2007; 131: 148-55.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical